USPTO Delivers Setback To Genentech
In a blow for Genentech Inc., regulators at the United States Patent & Trademark Office have called into question the patent at the center of the biotech's longstanding royalty battle with...To view the full article, register now.
Already a subscriber? Click here to view full article